Quantcast

Latest dialysis Stories

2014-07-10 04:21:24

STOCKHOLM, July 10, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, has had core patents for its late-stage clinical candidate Nefecon(R) issued in the key markets United States, Europe, China and Hong Kong. A patent is pending in Japan. Nefecon is a potential disease-modifying treatment for patients with primary IgA nephropathy at risk of developing end-stage renal disease. Nefecon has shown positive results in an...

2014-07-09 08:27:28

World-class Nephrologist to Lead Home Dialysis Program DENVER, July 9, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company has named Martin Schreiber, M.D., as its new vice president of clinical affairs for home modalities. http://photos.prnewswire.com/prnvar/20140303/LA75036LOGO-b DaVita's home hemodialysis (HHD) and peritoneal dialysis (PD)...

2014-07-08 23:01:41

The Firm is representing numerous GranuFlo lawsuit clients who allegedly suffered catastrophic heart events due to the use of GranuFlo or NaturaLyte dialysis concentrates. New York, New York (PRWEB) July 08, 2014 GranuFlo lawsuits (http://www.thegranuflolawsuit.com) filed in the wake of the 2012 GranuFlo and NaturaLyte dialysis concentrate recall continue to move forward in courts throughout the U.S., Bernstein Liebhard LLP reports. According to court documents filed on July 3rd, a...

2014-07-08 08:31:07

Special Guest Recording Artist and Former NxStage System One patient, David RUSH LAWRENCE, Mass., July 8, 2014 /PRNewswire/ -- WHAT: NxStage Kidney Care will be hosting a Grand Opening celebration and ribbon cutting reception for its new state-of-the- art dialysis center in Jacksonville, Florida. The Grand Opening event, which is open to the public, will include a ribbon cutting reception, tours of the 6,300 sq. ft. facility, and an opportunity to...

2014-07-04 23:02:00

Fresenius Medical Care North America Recalls 56 Lots of Liquid Bicarbonate Concentrate DALLAS (PRWEB) July 04, 2014 Fresenius Medical Care North America, manufacturer of the dialysis drugs GranuFlo and NaturaLyte, has recalled 56 lots of NaturaLyte due to finding higher bacteria levels than allowed by internal specifications. The company is involved in litigation in a Massachusetts federal court where more than 1,700 lawsuits have been filed in conjunction with a previous recall. (In Re:...

2014-07-03 16:23:16

WASHINGTON, July 3, 2014 /PRNewswire-USNewswire/ -- Kidney Care Partners (KCP) expressed concern that a combination of flat payments and increased regulatory pressures proposed by the Centers for Medicare and Medicaid Services (CMS) may negatively impact stability and affect quality of care in Medicare's end-stage renal disease (ESRD) program. KCP is a coalition of patient advocates, clinicians, care professionals, dialysis providers, researchers, and manufacturers working together...

2014-07-03 12:25:51

NxStage Patients embrace the flexibility of home hemodialysis to reclaim their lifestyles and live freely LAWRENCE, Mass., July 3, 2014 /PRNewswire/ -- In honor of Independence Day, NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, joins patients across the nation in celebrating the freedom and flexibility they have reclaimed with home hemodialysis (HHD) using the NxStage® System One(TM)....

2014-07-03 11:16:59

NIH/National Institute of Diabetes and Digestive and Kidney Diseases NIH study suggests people with either should be monitored for both Acute kidney injury (AKI) and chronic kidney disease (CKD) are closely intertwined, with each disease a risk factor for developing the other and sharing other risk factors in common, as well as sharing causes for the diseases to get worse, and outcomes, suggests a comprehensive analysis by scientists at the National Institutes of Health and George...

2014-07-01 16:26:22

After Review of Three Renal Anemia Product Profiles in Development, Expected Use Increases with Disease Severity, According to Findings from Decision Resources Group BURLINGTON, Mass., July 1, 2014 /PRNewswire/ -- Decision Resources Group finds that patient chart data submitted by surveyed nephrologists in China reveals that, consistent with 2011, the percentage of patients on erythropoiesis-stimulating agents (ESAs) significantly increases as chronic kidney disease (CKD) worsens; however,...

2014-06-30 23:08:43

The Firm is representing numerous GranuFlo lawsuit clients who allegedly suffered serious cardiac injuries due to products included in the 2012 GranuFlo and NaturaLyte recall. New York, NY (PRWEB) June 30, 2014 GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) stemming from the 2012 GranuFlo and NaturaLyte dialysis concentrate recall continue to mount in courts around the U.S., Bernstein Liebhard LLP reports. According to an article published by the Associated Press on June 28th,...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.